Want to see ALLO full AI Analyst Report?

Allogene Therapeutics (ALLO) Revenue

1,832 Followers

Allogene Therapeutics Revenue

Allogene Therapeutics had a revenue of 4.64M in the quarter ending Jun 30, 2026, with Infinity%. This bring the company's revenue in the last twelve months to 4.64M, Decreased Infinity%. In the fiscal year ending Dec 31, 2025, Allogene Therapeutics had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

4.64M

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

151

Market Cap

$680.62M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-22.00K	-100.00%
Dec 31, 2024	22.00K	-73.00K	-76.84%
Dec 31, 2023	95.00K	-61.00K	-39.10%
Dec 31, 2022	156.00K	-113.93M	-99.86%
Dec 31, 2021	114.09M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―